Newborn screening programs for spinal muscular atrophy worldwide in 2023
The data shows a significant increase in the implementation of newborn screening programs since 2021. The experts are still expressing a strong need for equitable access to standard of care for all the patients globally. Despite all setbacks, collaborative efforts have played a crucial role in newborn screening for spinal muscular atrophy implementation and currently 7% of world newborns are being screened, projections indicate an estimated 18% screening rate by 2028.
Authors
- Damjan Osredkar (ORCID: https://orcid.org/0000-0002-2188-420X)
- Tamara Dangouloff (ORCID: https://orcid.org/0000-0002-5435-4774)
- Eva Vrščaj (ORCID: https://orcid.org/0000-0002-1510-0501)
- Laurent Servais (ORCID: https://orcid.org/0000-0001-9270-4061)
Institutions
- University of Ljubljana (SI)
- University of Liège (BE)
- Ljubljana University Medical Centre (SI)
- University of Oxford (GB)
Publication Details
- Journal
- Journal of Neuromuscular Diseases
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1177/22143602241288095
- Citations
- 22
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 9.63